Literature DB >> 29672296

Predictive Factors of Portal Hypertensive Enteropathy Exacerbation in Patients with Liver Cirrhosis: A Capsule Endoscopy Study.

Sayoko Kunihara1, Shiro Oka1, Shinji Tanaka2, Ichiro Otani1, Atsushi Igawa1, Yuko Nagaoki1, Hiroshi Aikata1, Kazuaki Chayama1.   

Abstract

BACKGROUND/AIMS: The clinical course and exacerbation of portal hypertensive enteropathy (PHE) are yet to be fully clarified. This study aimed to identify factors related to PHE exacerbation in patients with liver cirrhosis (LC).
METHODS: Fifty patients with LC (33 male; mean age, 67 years), who underwent capsule endoscopy (CE) at the Hiroshima University Hospital between February 2009 and September 2015, were followed up for >6 months. Exacerbation is defined as the appearance of new lesions or worsening of existing lesions. The association between PHE exacerbation and the clinical factors was evaluated.
RESULTS: PHE exacerbation was identified in 24 out of 50 (48%) of cases: erythema (14 cases); angioectasia (11 cases); erosions (9 cases); villous edema (8 cases); and esophageal varices (EVs; 6 cases). The following factors were significantly associated with PHE exacerbation: portosystemic shunts, EVs and portal hypertensive gastropathy (PHG) exacerbation. After therapy, CE findings among the 24 cases were as follows: villous edema (19 cases); erythema (17 cases); angioectasia (16 cases); erosions (12 cases); and EVs (9 cases), and no observable abnormalities in 2 cases. On multivariate analysis, exacerbation of EVs and PHG were independent predictors of PHE exacerbation.
CONCLUSION: EVs and PHG exacerbation may predict PHE exacerbation in patients with LC.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Portal hypertensive enteropathy; Capsule endoscopy; Esophageal varices; Liver cirrhosis ; Portal hypertensive gastropathy

Mesh:

Year:  2018        PMID: 29672296     DOI: 10.1159/000486666

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  2 in total

1.  Management of occult obscure gastrointestinal bleeding patients based on long-term outcomes.

Authors:  Sayoko Kunihara; Shiro Oka; Shinji Tanaka; Akiyoshi Tsuboi; Ichiro Otani; Kazuaki Chayama
Journal:  Therap Adv Gastroenterol       Date:  2018-07-16       Impact factor: 4.409

2.  Clinical features of obscure gastrointestinal bleeding undergoing capsule endoscopy: A retrospective cohort study.

Authors:  Yuga Komaki; Shuji Kanmura; Kazuki Yutsudo; Kosuke Kuwazuru; Fukiko Komaki; Akihito Tanaka; Hidehito Maeda; Shiho Arima; Shiroh Tanoue; Fumisato Sasaki; Shinichi Hashimoto; Masahisa Horiuchi; Akio Ido
Journal:  PLoS One       Date:  2022-03-24       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.